Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AKUMS Akums Drugs and Pharmaceuticals Limited Pharma · Large | SYNGENE Syngene International Limited Pharma · Small | COHANCE Cohance Lifesciences Limited Pharma · Small | DCAL Dishman Carbogen Amcis Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 45 | 29 | 30 | 55 |
| Verdict | WATCHLIST | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | Financial Turnaround | OVERVALUED | OVERVALUED | Growth at Value |
| Piotroski | 8/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 7/30 | 2/30 | 1/30 | 16/30 |
| Growth | 15/25 | 7/25 | 7/25 | 20/25 |
| Quality | 1/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 12/15 | 11/15 | 10/15 | 4/15 |
| Cash Flow | 5/10 | 4/10 | 6/10 | 10/10 |
| Price | ₹544.45 | ₹444.3 | ₹432.4 | ₹189 |
| P/E | 32.00 | 48.30 | 82.30 | 29.10 |
| P/B | 2.58 | 3.75 | 4.16 | 0.43 |
| ROE | 8.45% | 7.86% | 7.04% | 1.58% |
| ROCE | 14.90% | 10.10% | 8.35% | 3.15% |
| Debt / Equity | 0.05 | 0.09 | 0.10 | 0.46 |
| FCF Yield | 2.92% | 0.30% | 0.70% | 8.52% |
| Dividend Y | 0.18% | 0.28% | — | — |
| Altman Z | 4.59 | 7.00 | 7.19 | 1.71 |
| Promoter % | 75.26% | 52.68% | 57.49% | 59.32% |
| Mkt Cap (₹Cr) | 8582.00 | 18147.00 | 16238.00 | 2887.00 |
| Graham # | ₹277.41 | ₹145.68 | ₹103.64 | ₹244.17 |
| Fair PE | 42.0 | 8.3 | 3.8 | 42.0 |
| MoS % | +20.0% | -581.9% | -2350.7% | +27.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAKUMS69
SYNGENE49
COHANCE40
DCAL99